rs2302974

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000517412.2(PIK3R1):​n.1108A>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 1,185,912 control chromosomes in the GnomAD database, including 24,471 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3288 hom., cov: 31)
Exomes 𝑓: 0.20 ( 21183 hom. )

Consequence

PIK3R1
ENST00000517412.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.69

Publications

4 publications found
Variant links:
Genes affected
PIK3R1 (HGNC:8979): (phosphoinositide-3-kinase regulatory subunit 1) Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]
PIK3R1 Gene-Disease associations (from GenCC):
  • immunodeficiency 36 with lymphoproliferation
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • SHORT syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • agammaglobulinemia 7, autosomal recessive
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal agammaglobulinemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 5-68273563-A-C is Benign according to our data. Variant chr5-68273563-A-C is described in ClinVar as Benign. ClinVar VariationId is 1277601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.22 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIK3R1NM_181523.3 linkc.427+81A>C intron_variant Intron 3 of 15 ENST00000521381.6 NP_852664.1 P27986-1A0A2X0SFG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIK3R1ENST00000521381.6 linkc.427+81A>C intron_variant Intron 3 of 15 1 NM_181523.3 ENSP00000428056.1 P27986-1

Frequencies

GnomAD3 genomes
AF:
0.205
AC:
31077
AN:
151796
Hom.:
3279
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.223
Gnomad AMI
AF:
0.203
Gnomad AMR
AF:
0.154
Gnomad ASJ
AF:
0.221
Gnomad EAS
AF:
0.177
Gnomad SAS
AF:
0.221
Gnomad FIN
AF:
0.230
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.201
Gnomad OTH
AF:
0.200
GnomAD4 exome
AF:
0.199
AC:
206193
AN:
1033998
Hom.:
21183
Cov.:
14
AF XY:
0.200
AC XY:
106558
AN XY:
532608
show subpopulations
African (AFR)
AF:
0.223
AC:
5544
AN:
24886
American (AMR)
AF:
0.107
AC:
4676
AN:
43566
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
4961
AN:
23330
East Asian (EAS)
AF:
0.179
AC:
6729
AN:
37696
South Asian (SAS)
AF:
0.215
AC:
16599
AN:
77280
European-Finnish (FIN)
AF:
0.227
AC:
11825
AN:
52020
Middle Eastern (MID)
AF:
0.171
AC:
845
AN:
4944
European-Non Finnish (NFE)
AF:
0.201
AC:
145346
AN:
723850
Other (OTH)
AF:
0.208
AC:
9668
AN:
46426
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
8437
16874
25310
33747
42184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4064
8128
12192
16256
20320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.205
AC:
31119
AN:
151914
Hom.:
3288
Cov.:
31
AF XY:
0.206
AC XY:
15282
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.224
AC:
9263
AN:
41410
American (AMR)
AF:
0.153
AC:
2339
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
767
AN:
3468
East Asian (EAS)
AF:
0.176
AC:
911
AN:
5172
South Asian (SAS)
AF:
0.222
AC:
1066
AN:
4800
European-Finnish (FIN)
AF:
0.230
AC:
2421
AN:
10548
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.201
AC:
13689
AN:
67940
Other (OTH)
AF:
0.204
AC:
430
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1230
2461
3691
4922
6152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
211
Bravo
AF:
0.198
Asia WGS
AF:
0.258
AC:
896
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 25% of patients studied by a panel of primary immunodeficiencies. Number of patients: 24. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.029
DANN
Benign
0.62
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2302974; hg19: chr5-67569391; COSMIC: COSV57124070; API